Metropolis Healthcare Ltd.
Snapshot View

View in App

Prices View details >>

1447.65 -35.35 ▼-2.4%

16 August 2022, 04:11:11 PM
Volume: 289,616

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.metropolisindia.com
Market Cap 7,412.00 Cr.
Enterprise Value(EV) 7,503.61 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 33.73 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 42.95 Trailing Twelve Months Ending 2022-06
Industry PE 47.92 Trailing Twelve Months Ending 2022-06
Book Value / Share 177.37 Trailing Twelve Months Ending 2022-06
Price to Book Value 8.17 Calculated using Price: 1,448.50
Dividend Yield 0.55 Period Ending 2022-03
No. of Shares Subscribed 5.12 Cr. 51,200,249 Shares
FaceValue 2
Company Profile
Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. It classifies its tests into ‘routine' tests such as blood chemistry analyses, blood cell counts and urine examination; ‘semi-specialized' tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and ‘specialized' tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics. It is focused on providing reliable test results as well as value-added services such as home collection of specimens and online access to test reports. It also offers customized wellness packages to its institutional customers as per their requirement.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.38%
1 Week
-5.33%
1 Month
+1.40%
3 Month
-25.63%
6 Month
-27.14%
1 Year
-45.80%
2 Year
-13.54%
5 Year
10 Year

Ratios View Details >>

8 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.77 26.16 36.47 30.38 30.17 27.33 30.07 27.31
Return on Capital Employed (%) 27.47 40.06 54.28 45.22 45.10 37.90 41.60 34.39
Return on Assets (%) 14.48 19.06 23.75 16.93 15.51 14.78 18.43 16.19

Balance Sheet View Details >>

Particulars 8 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 361 265 323 415 419 524 707 886
Non Curr. Liab. 10 1 16 148 142 195 111 362
Curr. Liab. 75 105 152 233 241 210 240 342
Minority Int. 23 20 21 14 1 2 1 2
Equity & Liab. 468 391 512 810 803 930 1,059 1,593
Non Curr. Assets 167 166 227 367 381 492 415 1,159
Curr. Assets 302 225 285 443 422 438 645 434
Misc. Exp. not W/O
Total Assets 468 391 512 810 803 930 1,059 1,593

Profit Loss View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 455 524 545 647 761 856 998 1,228 1,181
Other Income 6 22 26 8 8 9 12 18 17
Total Income 461 546 570 655 769 865 1,010 1,246 1,198
Total Expenditure -337 -388 -391 -469 -557 -619 -708 -880 -873
PBIDT 124 158 179 186 212 246 302 366 326
Interest -2 -2 -2 -4 -4 -13 -12 -25 -22
Depreciation -21 -21 -17 -19 -20 -39 -46 -63 -71
Taxation -33 -46 -53 -52 -63 -41 -61 -79 -60
Exceptional Items -8 -25 16
PAT 68 82 107 112 125 128 183 215 173
Minority Interest -7 -8 -8 -3 0 0 -1 -1
Share Associate -6 -1 -1
Other Related Items
Consolidated Net Profit 61 74 102 104 120 127 183 214 173
Adjusted EPS 62 77 107 109 24 25 36 42 34

Cash Flow View Details >>

Particulars 6 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 102 104 90 215 249 253
Cash Fr. Inv. -86 2 35 -105 62 -738
Cash Fr. Finan. -17 -87 -118 -55 -33 163
Net Change -1 19 7 55 278 -322
Cash & Cash Eqvt 26 43 51 107 387 66

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 50.81 50.57 50.39 50.38 50.37 50.33 49.50 49.79 49.79
Public 49.19 49.43 49.61 49.62 49.63 49.67 50.50 50.21 50.21
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 37.85 5.44 5.44 3.30 3.30 3.30 2.67 1.18 1.18

Announcements View Details >>

Fri, 12 Aug 2022
Recording of Analysts/Institutional Investor Meet/Con. Call
Metropolis Healthcare Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call
Fri, 12 Aug 2022
Newspaper Advertisements
Metropolis Healthcare Limited has informed the Exchange about Newspaper Publications of Unaudited Financial Results for the quarter ended June 30, 2022
Thu, 11 Aug 2022
Outcome of Board Meeting
Metropolis Healthcare Limited has informed the Exchange about Board Meeting held on 10-Aug-2022 to consider and approve Un-audited Financial results (Standalone & Consolidated) for the quarter ended June 30, 2022

Technical Scans View Details >>

Fri, 12 Aug 2022
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 3 Months High Decrease 3 Months
High Decrease 6 Months High Decrease 6 Months
High Decrease 1 Year High Decrease 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,443.18 914.60 +0.1%
Divi's Laboratories Ltd. 99,072.87 3,732.00 +0.2%
Cipla Ltd. 83,487.41 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. 71,536.21 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,537.70 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 53,261.16 1,569.90 +2.0%
Piramal Enterprises Ltd. 45,983.34 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.42 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.92 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.44 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.91 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.76 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.33 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 24.47 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.38 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.87 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.53 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.52 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.31 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.05 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,569.90 +2.0%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On Metropolis Healthcare Ltd.

Can I Buy Metropolis Health. Shares now?
What is the Share Price of Metropolis Health.?
What is the Relative Strength Index (RSI) Value of Metropolis Health.?
What is the Market Capital (MCAP) of Metropolis Health.?
What are the key metrics to analyse Metropolis Health.?
What is the Price Performance of Metropolis Health.?